Company / Shareholders' Equity
STAAR Surgical Company Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$344.2M
FY2025
5-year range
$159.9M / $397.3M
FY2021-FY2025
Trend
-13.4%
vs FY2024
Sector context
#121 of 161
Health Care
What the data says
STAAR Surgical Company's shareholders' equity of $344M is lower than 75% of companies in the Health Care sector (FY2025). Shareholders' Equity has fluctuated over the past 10 years, ranging from $38M in FY2018 to $397M in FY2024.
Based on SEC 10-K filings.
$344M in FY2025 with a 5-year CAGR of +21.0%.
Declined from $386M to $344M over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +0.8%
- 5-Year CAGR
- +21.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 25% in Health CareTop 75% of 161This company $344.2M Sector average $5.1B
▼
-93.2% below sector average
Key checks
Key Insights
- 5-year CAGR of +21.0%, indicating consistent growth.
- In FY2025, shareholders' equity decreased 13.4% year-over-year.
- Ranks #121 out of 161 companies in the Health Care sector.
- Peak shareholders' equity was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Negative profit margin: -6.4%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $344.2M | -13.4% |
| FY2024 | $397.3M | +2.9% |
| FY2023 | $386.0M | +14.8% |
| FY2022 | $336.1M | +110.2% |
| FY2021 | $159.9M | +20.7% |
| FY2020 | $132.4M | -17.2% |
| FY2019 | $159.9M | +321.8% |
| FY2018 | $37.9M | -2.4% |
| FY2017 | $38.8M | +2.5% |
| FY2016 | $37.9M | -2.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026